Article
Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 1 Nov 2013
Gill Uzma, Aziz Hafsa, Gill Muzaffar Lateef
Abstract excerpt
BACKGROUND: Rapid virological response (RVR) is now thought to be the strongest predictor of sustained virological response (SVR) in hepatitis C virus (HCV) patients undergoing antiviral therapy. It can be used as a guide to individualize treatment duration. The aim of this study was to assess the role of RVR in tailoring the duration of treatment. METHODS: Patients with HCV genotype 3 infections were enrolled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.